Mesoblast Limited is a biotechnology company developing regenerative medicine therapies, focusing on stem cell treatments for inflammatory diseases and immune-related conditions.
Ticker code: MSB
Sector: Healthcare | Industry: Biotechnology | Website: https://www.mesoblast.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $3,297,142,345 | $3,263,748,337 | 1282934798 | 64.91 | $2,140,300,249 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $599,130,534 | $161,551,008 | $128,157,000 | -12.1 | -398.3 | -5.6 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Positive | 6.4 | $10,577,444 | $12,774,758 | 6.77 | 17.5 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $2.570 | -1.2 | -3.4 | 7.1 | 2.0 | 43.6 | 91.1 |
MSB Price Chart with Volume and 3EMA
MSB Short Positions
Click HERE to understand why the above moving averages have been chosen.